Transcranial Magnetic Stimulation trials

Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms

RecruitingNCT07182058Phase: PHASE1, PHASE2Started 2026-01-01

Summary

This study tests a new, non-invasive brain stimulation device called Sphere V3.0 to help improve movement problems in people with Parkinson's disease. The device delivers gentle electrical signals to

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
80 Years

Locations

U LLC HeadquartersCleveland, Ohio, United States

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT07182058